Prevention of contrast-induced nephropathy: Time for nuance and a new guideline;Preventie van contrastnefropathie: Tijd voor nuance en een nieuwe richtlijn

Nederlands Tijdschrift voor Geneeskunde

Volumn 157, Issue 13, 2013, Pages

  Kooiman, Judith ^a   Van Der Molen, Aart J ^a   Cannegieter, Suzanne C ^a   Rabelink, Ton J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; PLACEBO;

CONTRAST INDUCED NEPHROPATHY; DISEASE ASSOCIATION; HUMAN; KIDNEY FUNCTION; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHYDRATION; REVIEW; ECONOMICS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE QUALITY; NOTE;

EVIDENCE-BASED MEDICINE; HEALTH CARE COSTS; HUMANS; QUALITY OF HEALTH CARE;

EID: 84876357443     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Richtlijn Voorzorgsmaatregelen bij jodiumhoudende contrastmiddelen. 's-Hertogenbosch/Utrecht: Nederlandse Vereniging voor Radiologie/CBO; 2007.
2. Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527-41.
3. RIVM. Medische Stralingstoepassingen. Trends in het aantal CT-onderzoeken. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 2010.
4. Murakami R, Hayashi H, Sugizaki K, et al. Contrast-induced nephropathy in patients with renal insufciency undergoing contrast-enhanced MDCT. Eur Radiol. 2012;22:2147-52.
5. Kunadian V, Zaman A, Spyridopoulos I, Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials. Eur J Radiol. 2011;79:48-55.
6. Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract. 2003;93:c29-34.
7. Chen SL, Zhang J, Yei F, et al. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the efect of hydration and acetylcysteine. Int J Cardiol. 2008;126:407-13.
8. Balemans CE, Reichert LJ, van Schelven BI, van den Brand JA, Wetzels JF. Epidemiology of contrast material-induced nephropathy in the era of hydration. Radiology. 2012;263:706-13.
9. Elseviers MM, Verpooten GA, De Broe ME, De Backer GG. Interpretation of creatinine clearance. Lancet. 1987;1(8530):457.
10. Seeliger E, Sendeski M, Rihal CS, Persson PB. Contrast-induced kidney injury: mechanisms, risk factors, and prevention. Eur Heart J. 2012;33:2007-15.
11. Kim IY, Lee SB, Lee DW, et al. Long-term efect of radiocontrast-enhanced computed tomography on the renal function of chronic kidney disease patients. Clin Exp Nephrol. 2012;16:755-9.
12. Kooiman J, Pasha SM, Zondag W, et al. Meta-analysis: Serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol. 2012;81:2554-61.
13. McCullough PA, Brown Jr. Efects of intra-arterial and intravenous iso-osmolar contrast medium (Iodixanol) on the risk of contrast-induced acute kidney injury: a meta-analysis. Cardiorenal Med. 2011;1:220-34.
14. Vermeeren MAP. Veiligheidsregels jagen kosten op. Med Contact (Bussum). 2011;66:2073-5.
15. Wi J, Ko YG, Kim JS, et al. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart. 2011;97:1753-7.